Barrow Hanley Mewhinney & Strauss Adds $55M in Fortive Corporation ($FTV)
Key Points
- Barrow Hanley Mewhinney & Strauss changed its Fortive Corporation ($FTV) stake by 10.95% last quarter, boosting to 9,181,833 shares worth $553.76 million.
- Wall Street's consensus rating on $FTV is Hold and an average price target of $64.31.
- $FTV last traded around $60.31.
Important disclosure: Podchat is not a registered investment adviser, broker-dealer, or financial planner. This article is for informational and educational purposes only and is not a recommendation to buy, sell, or hold any security. Content may be generated by automated systems using public filings, market data, and third-party sources, and may contain errors or omissions. Investing involves risk, including possible loss of principal. Past performance, insider activity, analyst ratings, price targets, sentiment scores, and hypothetical or backtested results are not guarantees of future performance. Please do your own research and consult a qualified professional before making investment decisions.
Barrow Hanley Mewhinney & Strauss increased its position in Fortive Corporation ($FTV) by 10.95% during the most recent quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 9,181,833 shares of Fortive Corporation after buying 906,181 shares during the quarter. Barrow Hanley Mewhinney & Strauss's holdings in Fortive Corporation were worth $553.76 million as of its most recent filing.
Fortive Corporation Stock Up 1.0%
Shares of Fortive Corporation ($FTV) traded around $60.31 on Saturday, up 1.0% for the day.
Fortive Corporation Earnings
Fortive Corporation Dividend
Analysts Set New Price Targets
About Fortive Corporation
Fortive Corporation designs, develops, manufactures, and markets products, software, and services in the United States, China, and internationally. It operates through Intelligent Operating Solutions and Advanced Healthcare Solutions segments. The Intelligent Operating Solutions segment provides advanced instrumentation, software, and services, including maintenance, repair, measurement and condition monitoring, facility and asset lifecycle software applications, and connected worker safety and compliance solutions for manufacturing, process industries, healthcare, utilities and power, communications and electronics, and other industries. This segment markets its products and services under the ACCRUENT, FLUKE, GORDIAN, INDUSTRIAL SCIENTIFIC, INTELEX, and SERVICECHANNEL brand names. The Advanced Healthcare Solutions segment provides critical workflow solutions comprising instrument sterilization, instrument tracking, biomedical test tools, radiation detection and safety monitoring, and end-to-end clinical productivity software and solutions under the ASP, CENSIS, FLUKE BIOMEDICAL, LANDAUER, and PROVATION brand names. Fortive Corporation was incorporated in 2015 and is headquartered in Everett, Washington.
Get Fortive Corporation alerts
New 13F filings, insider trades, and analyst moves on $FTV, sent to your inbox. Free, and you can unsubscribe anytime.
This instant news alert was generated by automated narrative technology and financial data from Podchat and public regulatory filings. It is for informational purposes only and is not financial advice.